Cigna could be on the hook for $2.1B if its deal with Express Scripts falls through

man counting money
Cigna could be forced to pay $2.1 billion if its acquisition of Express Scripts is blocked by regulators. (Julia_Sudnitskaya/Getty)

Cigna has a lot riding on its pending deal with Express Scripts.

According to the terms of the agreement, Cigna would have to pay as much as $2.1 billion to the pharmacy benefit manager if the deal faces opposition from regulators. The insurer may have to pay the fee if the deal is terminated due to “a legal restraint relating to a regulatory law prohibiting consummation of the merger,” according to a Securities and Exchange Commission filing.

Under the agreement, either Cigna or Express Scripts would be required to pay a slightly lower $1.6 billion breakup fee if the deal falls through because the company’s board of directors changes its recommendations or if stockholders vote against the merger.

Digital Transformation

Unlock the Digital Front Door with an App

The Member Mobile App is the smarter and better way to engage members anytime and anywhere. Members can find the right doctors, receive alerts, track spending, use telehealth, and more — all within a guided, intuitive, and seamless experience. Built exclusively for payers, it is ready to install and launch in a few months. Request a consult on how to enable the digital front door with the Mobile App, today.

In March, the Department of Justice issued its second request to each company, and indication regulators are closely scrutinizing the deal. On an earnings call this week, CEO David Cordani emphasized the acquisition would cut down on specialty drug costs, generating savings that would be passed on to members.

RELATED: DOJ taking a closer look at Cigna-Express Scripts merger

Cigna is in the midst of its own legal battle with Anthem after a planned merger was blocked by a federal judge last year. The Connecticut insurer is seeking a $1.85 billion breakup fee from Anthem, in addition to $13 billion for harm it caused shareholders. Cigna is relying on that money to fund its Express Scripts purchase.

CVS-Aetna, the other massive merger undergoing a regulatory review, also includes a $2.1 billion termination fee.

Suggested Articles

Payers and PBMs need to be preparing now for the wave of CAR-T therapies coming through the drug development pipeline, according to a new report.

A CMMI review of value-based payment models gave high marks to models on home health and Maryland's total cost of care demonstration.

Walmart is piloting drone delivery of home sample collection kits for COVID-19 in partnership with Quest Diagnostics.